These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36396584)

  • 1. Surgical Management and Oncologic Outcomes for Local Retroperitoneal Recurrence of Renal Cell Carcinoma After Radical Nephrectomy.
    Huang J; Wang Y; Zhang C; Hu X; Wang P; Shi G; Dong L; Zhang J; Kong W; Chen Y; Xia D; Guo J; Xue W; Huang Y; He Z
    Clin Genitourin Cancer; 2023 Apr; 21(2):315.e1-315.e7. PubMed ID: 36396584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special issue "The advance of solid tumor research in China": Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy.
    Wang Y; Huang J; Zhang C; Hu X; Wang P; Shi G; Zhang J; Kong W; Chen Y; Huang Y; Ye D; Xia D; Guo J; He Z; Xue W
    Int J Cancer; 2023 Jan; 152(1):24-30. PubMed ID: 35712762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy.
    Staník M; Poprach A; Littnerová S; Čapák I; Hulová M; Šebová N; Lakomý R; Jarkovský J; Doležel J
    Urol Oncol; 2022 Mar; 40(3):111.e27-111.e34. PubMed ID: 34961683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
    Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
    BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.
    Thomas AZ; Adibi M; Borregales LD; Hoang LN; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
    J Urol; 2015 Aug; 194(2):316-22. PubMed ID: 25758610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma.
    Russell CM; Lue K; Fisher J; Kassouf W; Schwaab T; Sexton WJ; Tanguay S; Psutka SP; Thompson RH; Leibovich BC; Hanzly MI; Spiess PE; Boorjian SA
    BJU Int; 2016 Jun; 117(6B):E60-6. PubMed ID: 26118331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal fossa recurrence after radical nephrectomy: Current management, and oncological outcomes.
    Romeo A; Garcia Marchiñena P; Jurado AM; Gueglio G
    Urol Oncol; 2020 Feb; 38(2):42.e7-42.e12. PubMed ID: 31711833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
    Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
    J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surgical management for local retroperitoneal recurrence of 33 renal cell carcinoma patients underwent radical nephrectomy].
    Huang JW; Cai W; Kong W; Zhang J; Chen YH; Huang YR
    Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):703-707. PubMed ID: 31550862
    [No Abstract]   [Full Text] [Related]  

  • 11. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
    Lau WK; Blute ML; Weaver AL; Torres VE; Zincke H
    Mayo Clin Proc; 2000 Dec; 75(12):1236-42. PubMed ID: 11126830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
    Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
    World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
    Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
    Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland.
    Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC
    Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma.
    Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ
    Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
    Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathologic features and prognostic analyses of locally recurrent renal cell carcinoma patients after initial surgery].
    Tang Q; Lin RC; Yao L; Zhang Z; Hao H; Zhang CJ; Cai L; Li XS; He ZS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 51(4):628-631. PubMed ID: 31420612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.